Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Diet can influence inflammatory skin diseases.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Vitamin D might help treat alopecia areata.

Reducing CD8+ T cell growth can stabilize alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.